SR One

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is SR One's primary sector concentration for investments?

SR One primarily concentrates its investments in the Health Tech & Life Sciences sector, with all its recorded rounds and portfolio companies falling into this category.

When did SR One make its first investment, and in which company?

SR One made its first recorded investment in July 2014, participating in a $23 million round for Atox Bio.

Which companies are notable in SR One's portfolio?

SR One's portfolio includes Atox Bio, founded in 2003, and Fore Biotherapeutics, founded in 2011. For a full list, refer to startupim data.

Has SR One acted as a lead investor in any of its portfolio companies?

Yes, SR One has acted as a lead investor. For example, it led a $23 million round for Atox Bio in July 2014 and a $75 million round for Fore Biotherapeutics in August 2023.

What is the investment range for SR One's recorded deals?

SR One's recorded investments range from $23 million to $75 million per round.

What was SR One's most recent investment activity?

SR One's most recent investment was in August 2023, participating in a $75 million round for Fore Biotherapeutics, where it acted as a lead investor.

How many investment rounds has SR One participated in over time?

SR One has participated in four recorded investment rounds: one in 2014, one in 2017, one in 2020, and one in 2023.

What funding stages does SR One typically invest in?

SR One has invested across various funding stages, including C Round, D Round, E Round, and F Round, with both initial and follow-on investments.